Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein X (CENPX) is a highly conserved DNA-binding protein that plays dual roles in chromosome biology: (1) it is essential for proper kinetochore architecture and function, supporting accurate chromosome alignment and segregation during mitosis; (2) it acts as a DNA repair factor within the Fanconi anemia (FA) pathway, partnering with CENP-S (MHF1) and FANCM to facilitate the resolution of complex DNA structures and support the repair of interstrand crosslinks and stalled replication forks. Its functions are critical for maintaining genome stability, and mutations in CENPX are associated with disorders such as Fanconi anemia and certain types of osteogenesis imperfecta
Mechanisms primarily relate to modulation of the Fanconi anemia DNA repair pathway, particularly the monoubiquitination of the FANCI-FANCD2 complex in response to DNA damage. Drugs that induce DNA cross-links may interact functionally by challenging the repair capacities mediated by CENPX/FANCM/MHF complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein X (CENPX).